Skip to main content

Day: August 28, 2020

Pipestone Energy Corp. Announces Extension to the Unplanned Outage at the Keyera Wapiti Gas Plant

CALGARY, Alberta, Aug. 28, 2020 (GLOBE NEWSWIRE) — (PIPE – TSX-V) Pipestone Energy Corp. (“Pipestone Energy” or the “Company”) was notified by Keyera Corp. (“Keyera”) on August 27, 2020 that the issue relating to the Waste Heat Recovery System within the Keyera Wapiti Gas Plant (“Keyera Plant”) is more widespread than previously indicated. The total scope of the problem and root cause of the outage has yet to be determined.  As such the original estimate provided by Keyera to repair the plant and return to operations is no longer valid. In addition at this time, Keyera is unable to provide a definitive indication for the expected go-forward outage duration.Based on this new development, Pipestone Energy is formally suspending its 2020 production and cash flow guidance due to the timing uncertainty for a return to normal operations...

Continue reading

Plus Therapeutics, Inc. to Present at The LD 500 Virtual Conference

AUSTIN, Texas, Aug. 28, 2020 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc (Exchange: PSTV) , today announced that it will be presenting at the LD 500 investor conference on Friday, September 4 at 10.20 AM ET. Dr. Marc Hedrick, President and CEO of Plus Therapeutics, will be hosting the presentation and answering questions from investors.Register here: https://ld500.ldmicro.com/“We have been waiting for this moment all year long. Due to COVID, it has been nearly impossible for physical conferences to even take place. I want to show the world that you can still learn, have a great time, and see some of the most unique companies in the capital markets today. All without having to step foot outside. For the first time, LD Micro is accessible to everyone, and we are honored to welcome you to one of the most trusted platforms in the...

Continue reading

Axsome Therapeutics to Present Data from the CONCERT Phase 2 Trial of AXS-12 in Narcolepsy at the SLEEP 2020 Annual Meeting

NEW YORK, Aug. 28, 2020 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced that it will present efficacy and safety data from the CONCERT Phase 2 trial of AXS-12 in the treatment of narcolepsy at the 34th Annual SLEEP Meeting of the Associated Professional Sleep Societies (APSS). The meeting, which is a joint venture of the American Academy of Sleep Medicine (AASM) and the Sleep Research Society (SRS), is being held virtually from August 27 to 30. AXS-12 is a novel, oral, highly selective and potent norepinephrine reuptake inhibitor for the treatment of narcolepsy. Details of the poster presentation are as follows:Session: New Treatments for NarcolepsyTitle: Efficacy and Safety of AXS-12...

Continue reading

Evergold Amends Previously Announced $3.5 Million Private Placement Financing to Enable Participation by Existing Shareholders

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATESTORONTO, Aug. 28, 2020 (GLOBE NEWSWIRE) — Evergold Corp. (“Evergold” or the “Company“) (TSX-V: EVER, OTC: EVGUF, FRA: 5EG) is pleased to announce, further to shareholder inquiries, that it has amended the $3.5 million non-brokered private placement financing (the “Offering”) announced on August 26, 2020, to allow for participation by existing shareholders under the “Existing Shareholder Exemption” as described below. The Company also announces a change in price of the flow-through shares (“FT Shares”) component of the Offering to $0.60 per FT Share.“We’re happy to extend the Offering to existing shareholders using this mechanism,...

Continue reading

Razor Energy Corp. Announces Second Quarter 2020 Results

CALGARY, Alberta, Aug. 28, 2020 (GLOBE NEWSWIRE) — Razor Energy Corp. (“Razor” or the “Company”) (TSXV: RZE) announces its second quarter 2020 financial and operating results. Selected financial and operational information is outlined below and should be read in conjunction with Razor’s unaudited condensed consolidated interim financial statements and management’s discussion and analysis for the quarter ended June 30, 2020 which are available on SEDAR at www.sedar.com and the Company’s website www.razor-energy.com.Q2 2020 HIGHLIGHTSOPERATINGAchieved operating expenses of $21.52/boe in the second quarter of 2020, down 33% from the same period in 2020 due to a strict focus in cost reductions and operating efficiencies. Razor operated properties realized operating expenses of $22.32/boe for the six months ended June 30, 2020 while...

Continue reading

1847 Holdings Announces Uplisting to OTCQB

NEW YORK, Aug. 28, 2020 (GLOBE NEWSWIRE) — 1847 Holdings LLC (OTC: EFSH), a publicly traded holding company platform that combines the attractive attributes of private, lower-middle market businesses with the liquidity and transparency of a publicly traded company, today announced that its common stock was approved for quotation on the OTC Markets Group, Inc.’s OTCQB® tier Venture Market (the “OTCQB”) under the symbol “EFSH” effective as of the open of trading on August 28, 2020.“Uplisting to the OTCQB is an important milestone in 1847 Holdings’ history,” stated Ellery W. Roberts, CEO. “We believe that the broader exposure afforded by the OTCQB will increase our visibility within the investment community and assist in broadening our stockholder base.” The OTCQB is a venture market operated by the OTC Markets Group, Inc. and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.